Abundance Bets Big on PureCycle, Adding 6.7 Million Shares of the Heavily Shorted Stock

Abundance Wealth Counselors increased its PureCycle Technologies stake by 6,722,837 shares in Q1, an estimated $55.99 million purchase, lifting its post-trade holding to 8,536,527 shares worth $44.30 million as of March 31, 2026. PureCycle now represents 6.35% of fund AUM and remains a top holding, signaling conviction despite the company’s negative earnings profile and 40.15% short interest. The stock traded at $7.18 on April 22, up 12.4% year over year, but the filing is more a position signal than a direct catalyst.

Analysis

This is less a simple value-add filing than a forced signaling event: a fund taking PCT to a mid-single-digit AUM weight implies conviction in either a step-change in commercialization or a structural squeeze in float. With short interest still extremely elevated, incremental buying can have outsized reflexivity over the next 1-3 months, especially into the May 6 update when positioning will likely be re-tested. The setup is asymmetric because the stock does not need a clean fundamentals beat to rally; merely credible evidence that project milestones and customer adoption are de-risking can trigger short covering.

The second-order winner is the broader recycling/industrial circularity stack, not just PCT. A successful European grant-backed buildout would validate the economics of high-purity recycled polypropylene and could pull forward procurement decisions from packaging and consumer-goods buyers that are currently waiting for proof of supply reliability. That said, the market is still pricing PCT more like a financing-and-execution option than a stable operating business, so any hiccup in ramp timing, capex, or grant-linked deliverables would hit hard because the equity has little margin for error.

The contrarian point is that crowded short interest cuts both ways: it makes the stock vulnerable to squeezes, but also suggests sophisticated investors still doubt the path to self-funding. The key question is whether management can convert policy support and partnerships into repeatable unit economics before capital intensity forces another dilution cycle. If the next update shows better throughput or commercial traction, the move can extend for months; if not, the stock likely reverts quickly as squeeze dynamics exhaust.

Key Decisions for Investors

• Long PCT into the May 6 quarterly update via common stock or near-dated calls; target a 1-2 month event-driven trade where upside is driven by short-covering and milestone validation, with tight risk controls if management sounds vague on ramp timing.
• Use a pair trade: long PCT / short a basket of low-quality industrial recyclers or high-short-interest small caps to isolate squeeze-plus-catalyst exposure while reducing broad market beta.
• If already long PCT, monetize part of the position into any pre-earnings run-up; the stock is vulnerable to a classic 'good news already in the price' reversal once event risk passes.
• For more conservative exposure, wait for post-earnings confirmation of throughput and financing clarity before adding; missing the first leg may be preferable to owning a capital-intensive story ahead of execution risk.
• Sell downside protection on PCT only if borrowing/option premiums remain elevated and you are comfortable owning through a volatility event; otherwise avoid naked premium capture because a failed update could produce a fast drawdown.